IgA nephropathy trials in Argentina

In Argentina 7 Also abroad 92

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Where
Buenos Aires, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba
Age
18 years and over
People
347 worldwide
Run by
Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00
Phase 3Taking people
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Where
Almagro, Buenos Aires, La Boca, Rosario, San Miguel de Tucumán, Santa Fe
Age
18 years and over
People
454 worldwide
Run by
Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
CABA, Córdoba, Santa Fe
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Where
Córdoba
Age
2 years to 18 years
People
31 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06994845
Phase 3Taking people
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Where
Buenos Aires, CABA, Catamarca, La Plata, Santa Fe
Age
18 years to 100 years
People
220 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06858319
Phase 2Taking people
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Where
CABA, Córdoba
Age
18 years to 99 years
People
20 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06797518
Phase 2/3Enrolling by invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Where
Buenos Aires, Córdoba
Age
18 years and over
People
600 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659